S Brown

1.7k total citations
14 papers, 1.3k citations indexed

About

S Brown is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, S Brown has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in S Brown's work include Lymphoma Diagnosis and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S Brown is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S Brown collaborates with scholars based in United States, Ireland and Canada. S Brown's co-authors include Evelyne T. Edwards, Sharon K. Gershon, M. Miles Braun, Mark H. Greene, Ronald Levy, Jong‐Hoon Lee, Robert P. Wise, Nancy R. Slifman, Jeffrey Siegel and William D. Schwieterman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

S Brown

14 papers receiving 1.2k citations

Peers

S Brown
Margaret A. Alspaugh United States
S Pileri Italy
Pamela G. Kidd United States
Jan Hillson United States
KJ Trainor Australia
Allison Luo United States
Karen Qi United States
S Brown
Citations per year, relative to S Brown S Brown (= 1×) peers Marie‐Christine Jacob

Countries citing papers authored by S Brown

Since Specialization
Citations

This map shows the geographic impact of S Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Brown more than expected).

Fields of papers citing papers by S Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Brown. The network helps show where S Brown may publish in the future.

Co-authorship network of co-authors of S Brown

This figure shows the co-authorship network connecting the top 25 collaborators of S Brown. A scholar is included among the top collaborators of S Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Brown. S Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Theurer, Kristine A., W. Ben Mortenson, Robyn Stone, et al.. (2017). THE IMPACT OF PEER MENTORING IN RESIDENTIAL CARE ON THOSE VISITED. Innovation in Aging. 1(suppl_1). 238–239. 1 indexed citations
2.
Brown, S, et al.. (2006). Status of Acropora palmata populations off the coast of south Caicos, Turks and Caicos Islands. AquaDocs (United Nations Educational, Scientific and Cultural Organization). 3 indexed citations
3.
Brown, S, et al.. (2004). Music, identity and social control. Research Explorer (The University of Manchester). 7 indexed citations
4.
Lee, Jong‐Hoon, Nancy R. Slifman, Sharon K. Gershon, et al.. (2002). Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept. Arthritis & Rheumatism. 46(10). 2565–2570. 337 indexed citations
5.
Brown, S, Mark H. Greene, Sharon K. Gershon, Evelyne T. Edwards, & M. Miles Braun. (2002). Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration. Arthritis & Rheumatism. 46(12). 3151–3158. 488 indexed citations
7.
Knox, SJ, Ronald Levy, Suzanne Hodgkinson, et al.. (1991). Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides. Blood. 77(1). 20–30. 58 indexed citations
8.
Brown, S, et al.. (1990). A Review of the Social and Prevocational Information Battery. Journal of Counseling & Development. 68(3). 338–340. 2 indexed citations
9.
Press, Oliver W., Janet F. Eary, C Badger, et al.. (1989). Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.. Journal of Clinical Oncology. 7(8). 1027–1038. 219 indexed citations
10.
Levy, Ronald, Shoshana Levy, S Brown, S Kon, & W L Carroll. (1987). Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma.. PubMed. 22. 194–203. 1 indexed citations
11.
Ra, Miller, et al.. (1987). Anti-idiotypes in B-cell tumor therapy.. PubMed. 131–4. 9 indexed citations
12.
Eary, Janet F., C Badger, Oliver W. Press, et al.. (1987). TREATMENT OF B-CELL LYMPHOMA WITH I-131 LABELED MURINE MONOCLONAL ANTIBODIES.. Clinical Nuclear Medicine. 12(Supplement). P19–P19. 7 indexed citations
13.
Horning, Sandra J., et al.. (1986). Diagnosis of B cell lymphoma by analysis of immunoglobulin gene rearrangements in biopsy specimens obtained by fine needle aspiration.. Journal of Clinical Oncology. 4(3). 278–283. 37 indexed citations
14.
Brown, S, Jeanette Dilley, & Ronald Levy. (1980). Immunoglobulin secretion by mouse X human hybridomas: an approach for the production of anti-idiotype reagents useful in monitoring patients with B cell lymphoma.. The Journal of Immunology. 125(3). 1037–1043. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026